Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

Phospho-Cdc25C (Ser216) Antibody

Polyclonal antibody to detect endogenous levels of Cdc25C (pS216) in human samples
Catalog #: A1259
$285.00

Product Details

Cat # +Size A1259-100
Size 100 µl
Antibody Target CDC25C
Alternate Name M-phase inducer phosphatase 3, Dual specificity phosphatase Cdc25C, CDC25C
Host Rabbit
Antibody Type Polyclonal
Isotype Rabbit IgG
Immunogen Synthesized peptide derived from human Cdc25C around the phosphorylation site of S216.
Accession # P30307
Gene ID 995
Appearance Colorless liquid
Formulation In PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide
Purification Affinity-chromatography using epitope-specific immunogen
Species Reactivity Human
Application WB, ELISA, IHC
Positive Control WB: VEC, 293 and A549 cell lysates
Application & Usage WB 1:500-1:2000; IHC 1:100-1:300; ELISA 1:10000
Handling The antibody solution should be gently mixed before use.
Storage Conditions -20 °C
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.

Details

Functions as a dosage-dependent inducer in mitotic control. Tyrosine protein phosphatase required for progression of the cell cycle. When phosphorylated, highly effective in activating G2 cells into prophase. Directly dephosphorylates CDK1 and activates its kinase activity.


Why buy BioVision Products?
Innovation
Affordability
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.